Other News To Note
Tuesday, January 15, 2013
Telik Inc., of Palo Alto, said ezatiostat HCL (Telintra) was granted orphan designation by the FDA for the treatment of myelodysplastic syndrome. Telintra is designed to inhibit enzyme glutathione S-transferase P1-1.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.